Chronic Stress Promotes Epithelial-Mesenchymal Transition in Lung Carcinogenesis Through the Induction of TGF-1
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Chronic Stress Promotes Epithelial-Mesenchymal Transition in Lung Carcinogenesis Through the Induction of TGF-1
Authors
Keywords
-
Journal
International Journal of Pharmacology
Volume 19, Issue 5, Pages 673-690
Publisher
Science Alert
Online
2023-11-02
DOI
10.3923/ijp.2023.673.690
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer Statistics, 2021
- (2021) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Inflammation and Depression: A Public Health Perspective
- (2021) Alexander L. Chu et al. BRAIN BEHAVIOR AND IMMUNITY
- Lung Cancer 2020
- (2020) Brett C. Bade et al. CLINICS IN CHEST MEDICINE
- β 3 ‐Adrenoceptor as a potential immuno‐suppressor agent in melanoma
- (2019) Maura Calvani et al. BRITISH JOURNAL OF PHARMACOLOGY
- Inflammatory markers and treatment outcome in treatment resistant depression: A systematic review
- (2019) Chenghao Yang et al. JOURNAL OF AFFECTIVE DISORDERS
- The TGFβ-induced lncRNA TBILA promotes non-small cell lung cancer progression in vitro and in vivo via cis-regulating HGAL and activating S100A7/JAB1 signaling
- (2018) Zhiliang Lu et al. CANCER LETTERS
- TGF-β1/Smad2/3/Foxp3 signaling is required for chronic stress-induced immune suppression
- (2018) Haiju Zhang et al. JOURNAL OF NEUROIMMUNOLOGY
- Sucrose preference test for measurement of stress-induced anhedonia in mice
- (2018) Meng-Ying Liu et al. Nature Protocols
- EMT: Mechanisms and therapeutic implications
- (2018) Mohini Singh et al. PHARMACOLOGY & THERAPEUTICS
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Somatic symptoms vary in major depressive disorder in China
- (2018) Dongmei Zhao et al. COMPREHENSIVE PSYCHIATRY
- Epithelial-mesenchymal transition (EMT) beyond EGFR mutations per se is a common mechanism for acquired resistance to EGFR TKI
- (2018) Chien-Hui Weng et al. ONCOGENE
- Work stress and the risk of cancer: A meta‐analysis of observational studies
- (2018) Tingting Yang et al. INTERNATIONAL JOURNAL OF CANCER
- Depression
- (2018) Gin S Malhi et al. LANCET
- Chronic Unpredictable Mild Stress for Modeling Depression in Rodents:Meta-analysis of Model Reliability
- (2018) Svitlana Antoniuk et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Stress, catecholaminergic system and cancer
- (2016) O. Krizanova et al. STRESS-THE INTERNATIONAL JOURNAL ON THE BIOLOGY OF STRESS
- The stress of life: a modern complaint?
- (2014) Mark Jackson LANCET
- Targeting EMT in cancer: opportunities for pharmacological intervention
- (2014) Felicity M. Davis et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Unlocking the diagnosis of depression in primary care: Which key symptoms are GPs using to determine diagnosis and severity?
- (2013) Gin S Malhi et al. AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY
- Psychosocial stress and inflammation in cancer
- (2012) N.D. Powell et al. BRAIN BEHAVIOR AND IMMUNITY
- TGF-β signalling and its role in cancer progression and metastasis
- (2012) Yvette Drabsch et al. CANCER AND METASTASIS REVIEWS
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Depression and cancer mortality: a meta-analysis
- (2010) M. Pinquart et al. PSYCHOLOGICAL MEDICINE
- Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression
- (2009) Andrew H. Miller et al. BIOLOGICAL PSYCHIATRY
- TGF-β-induced epithelial to mesenchymal transition
- (2009) Jian Xu et al. CELL RESEARCH
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now